OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
30
Results
Show all
Save search
Copy query
Show results for
Unknown
(30)
Publication Date
Release Date
2010
(5)
2021
(4)
2008
(4)
2022
(3)
2015
(3)
2024
(2)
2018
(2)
2016
(2)
2014
(2)
2013
(1)
2012
(1)
2011
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.
Not available
S-EPMC7822874
|
biostudies-literature
Cite
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
Not available
S-EPMC3386495
|
biostudies-literature
Cite
Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery: The TIGHT K Randomized Clinical Trial.
Not available
S-EPMC11366075
|
biostudies-literature
Cite
Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial.
Not available
S-EPMC4335311
|
biostudies-literature
Cite
Are large clinical trials in orthopaedic trauma justified?
Not available
S-EPMC5909275
|
biostudies-literature
Cite
Why START? Reflections that led to the conduct of this large long-term strategic HIV trial.
Not available
S-EPMC4347998
|
biostudies-literature
Cite
Four consecutive yearly point-prevalence studies in Wales indicate lack of improvement in sepsis care on the wards.
Not available
S-EPMC8355110
|
biostudies-literature
Cite
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Not available
S-EPMC3235490
|
biostudies-literature
Cite
Wound irrigation does not affect health-related quality of life after open fractures: results of a randomized controlled trial.
Not available
S-EPMC6413805
|
biostudies-literature
Cite
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Not available
S-EPMC10207856
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets